The latest evidence on the impact of fatty liver on liver-related outcomes and mortality in chronic hepatitis B.
作者信息
Mao Xianhua, Mak Lung Yi, Seto Wai-Kay
机构信息
Department of Medicine, School of Clinical Medicine, The University of Hong Kong, Hong Kong.
State Key Laboratory of Liver Research, The University of Hong Kong, Hong Kong.
出版信息
Clin Mol Hepatol. 2023 Jul;29(3):690-692. doi: 10.3350/cmh.2023.0173. Epub 2023 May 30.
Abstract
摘要
相似文献
1
The latest evidence on the impact of fatty liver on liver-related outcomes and mortality in chronic hepatitis B.
Clin Mol Hepatol. 2023 Jul;29(3):690-692. doi: 10.3350/cmh.2023.0173. Epub 2023 May 30.
2
[Clinical study of non-alcoholic fatty liver disease and its combined the chronic HBV infection].
Zhonghua Gan Zang Bing Za Zhi. 2017 Aug 20;25(8):618-622. doi: 10.3760/cma.j.issn.1007-3418.2017.08.012.
3
Fatty liver reduces hepatitis B virus replication in a genotype B hepatitis B virus transgenic mice model.
J Gastroenterol Hepatol. 2012 Dec;27(12):1858-64. doi: 10.1111/j.1440-1746.2012.07268.x.
4
Impact of non-alcoholic fatty liver disease on chronic hepatitis B.
Liver Int. 2007 Jun;27(5):607-11. doi: 10.1111/j.1478-3231.2007.01482.x.
5
[Impact of liver steatosis on antiviral effects of pegylated interferon-alpha in patients with chronic hepatitis B].
Zhonghua Gan Zang Bing Za Zhi. 2012 Apr;20(4):285-8. doi: 10.3760/cma.j.issn.1007-3418.2012.04.012.
6
Association between hepatic steatosis and entecavir treatment failure in Chinese patients with chronic hepatitis B.
PLoS One. 2012;7(3):e34198. doi: 10.1371/journal.pone.0034198. Epub 2012 Mar 30.
7
[Model building-up and observation on the mouse carried chronic hepatitis B and nonalcoholic fatty liver disease].
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi. 2013 Oct;27(5):332-5.
8
Impact of NAFLD on the outcome of patients with chronic hepatitis B in Asia.
Liver Int. 2022 Aug;42(9):1981-1990. doi: 10.1111/liv.15252. Epub 2022 Jul 7.
9
Inverse relationship between hepatic steatosis and hepatitis B viremia: Results of a large case-control study.
J Viral Hepat. 2018 Jan;25(1):97-104. doi: 10.1111/jvh.12766. Epub 2017 Aug 25.
10
Chronic hepatitis B and fatty liver: Issues in clinical management.
Clin Res Hepatol Gastroenterol. 2016 Dec;40(6):755-759. doi: 10.1016/j.clinre.2015.12.011. Epub 2016 Feb 2.
引用本文的文献
1
Hepatitis B Virus and microRNAs: A Bioinformatics Approach.
Int J Mol Sci. 2023 Dec 7;24(24):17224. doi: 10.3390/ijms242417224.
本文引用的文献
1
Impact of fatty liver on long-term outcomes in chronic hepatitis B: a systematic review and matched analysis of individual patient data meta-analysis.
Clin Mol Hepatol. 2023 Jul;29(3):705-720. doi: 10.3350/cmh.2023.0004. Epub 2023 May 8.
2
Hepatitis B.
Lancet. 2023 Mar 25;401(10381):1039-1052. doi: 10.1016/S0140-6736(22)01468-4. Epub 2023 Feb 9.
3
Forecasted 2040 global prevalence of nonalcoholic fatty liver disease using hierarchical bayesian approach.
Clin Mol Hepatol. 2022 Oct;28(4):841-850. doi: 10.3350/cmh.2022.0239. Epub 2022 Sep 19.
4
Steatosis, HBV-related HCC, cirrhosis, and HBsAg seroclearance: A systematic review and meta-analysis.
Hepatology. 2023 May 1;77(5):1735-1745. doi: 10.1002/hep.32792. Epub 2023 Apr 17.
5
Increased risk of hepatocellular carcinoma and mortality in chronic viral hepatitis with concurrent fatty liver.
Aliment Pharmacol Ther. 2022 Jan;55(1):97-107. doi: 10.1111/apt.16706. Epub 2021 Nov 24.
6
Hepatic steatosis and development of type 2 diabetes: Impact of chronic hepatitis B and viral specific factors.
J Formos Med Assoc. 2022 Aug;121(8):1478-1487. doi: 10.1016/j.jfma.2021.10.014. Epub 2021 Nov 8.
7
Animal Models for the Study of Hepatitis B Virus Pathobiology and Immunity: Past, Present, and Future.
Front Microbiol. 2021 Jul 16;12:715450. doi: 10.3389/fmicb.2021.715450. eCollection 2021.
8
Controlled attenuation parameter value and the risk of hepatocellular carcinoma in chronic hepatitis B patients under antiviral therapy.
Hepatol Int. 2021 Aug;15(4):892-900. doi: 10.1007/s12072-021-10205-7. Epub 2021 Jul 14.
9
Reduced hepatic steatosis is associated with higher risk of hepatocellular carcinoma in chronic hepatitis B infection.
Hepatol Int. 2021 Aug;15(4):901-911. doi: 10.1007/s12072-021-10218-2. Epub 2021 Jun 21.
10
Association Between Fatty Liver and Cirrhosis, Hepatocellular Carcinoma, and Hepatitis B Surface Antigen Seroclearance in Chronic Hepatitis B.
J Infect Dis. 2021 Jul 15;224(2):294-302. doi: 10.1093/infdis/jiaa739.
Zotero 插件